comprehensive -WSS

comprehensive

author：fashion 2025-10-01 21:36:34 - browse：469

Illustration of a bear on a red arrow with a bull underneath pushing the arrow upward. -- biotech coverage from STAT — Adobe

This was supposed to be the year of the biotech comeback, when promising new medicines and high-dollar buyouts would reverse a sector-wide slump that dates back to 2021. Instead, biotech stocks have dramatically underperformed the broader market, and the year’s few green shoots are yet to grow into a turnaround.

The closely watched XBI biotech index has fallen more than 10% in 2023, while the S&P 500 rose about 13% in the same period. Privately held companies have struggled to raise new capital without taking a hit to their valuations, and biotech IPOs have been rare in number and inconsistent in return.

The problem, analysts and investors said, is that the generalist investors who steer trillions of dollars of capital have simply soured on biotech. The furor over novel weight loss medicines like Wegovy has largely been a Big Pharma phenomenon, and rising interest rates have steered fund managers away from risky biotech stocks. The sector has gone through boom and bust cycles in the past, and it’s difficult, if not impossible, to predict when the macro winds might change and make biotech as popular as it was in the early days of Covid-19.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Leon Gautier, last member of French D

hotspot

WSS

Masked assailants attack a journalist and a lawyer in Russia's Chechnya province

Greece's new parliament sworn in following conservative party's election victory

Man killed during FBI raid in connection with threats against Biden, other officials

US judge blocks portions of new Florida elections law

Shkreli is convicted of fraud. Can pharma finally slam the door on him?

Wayne Brady comes out as pansexual: 'Free to love whomever I want'

focus

comprehensive

knowledge

Wildfire smoke exposes gaps in outdoor worker protections

A biotech analyst on neuroscience, placebo effect, not over

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Churchill Downs extends trainer Bob Baffert's ban through 2024

Medicare proposal to cover medical devices draws a mixed reaction

Churchill Downs extends trainer Bob Baffert's ban through 2024

23andMe had bad news about my health. I wish a person had delivered it

Michigan man accused of striking an officer during the US Capitol attack is arrested in Florida

Supreme Court strikes down use of affirmative action

What to know about Virgin Galactic's 1st mission taking paying customers to space

explore

A biotech analyst on neuroscience, placebo effect, not over

Trump pressured former Arizona governor to overturn 2020 election results: Sources

Kremlin open to talks over potential prisoner swap involving detained US reporter Evan Gershkovich

What to know about Virgin Galactic's 1st mission taking paying customers to space

Wegovy’s successful heart trial raises vital question about weight loss

The best solution to the drug shortages problem

focus

explore

hotspot

leisure time